Semaglutide vs Spermidine

Mechanism

Semaglutide is a GLP-1 receptor agonist with 94% structural homology to native GLP-1, modified with amino acid substitutions and a C-18 fatty acid chain that enables albumin binding, extending half-life to approximately 7 days. Centrally, it activates anorexigenic POMC/CART neurons and inhibits orexigenic NPY/AgRP neurons in the arcuate nucleus of the hypothalamus, reducing hunger and increasing satiety. Peripherally, it slows gastric emptying, enhances glucose-dependent insulin secretion from pancreatic beta-cells, and reduces glucagon secretion, providing comprehensive metabolic regulation.

Standard Dosing

Research indicates 0.25 mg weekly SC for 4 weeks, escalating to 0.5 mg, then 1.0 mg, then 1.7 mg, then 2.4 mg weekly (FDA weight management protocol). Oral: 3 mg daily for 30 days, then 7 mg, then 14 mg daily.

Timing

SC injection any time of day, with or without food, on the same day each week. Oral: take on empty stomach with no more than 4 oz water, 30+ minutes before first food/drink/medications.

Cycle Duration

Long-term/continuous use. Weight regain occurs upon discontinuation (67% regain within 1 year in trials).

Side Effects

• Nausea (44% — most common)
• Vomiting
• Diarrhea
• Constipation
• Abdominal pain
• Injection site reactions
• Headache
• Fatigue
• Gallbladder events
• Acute pancreatitis (rare)
• Potential lean mass loss

Contraindications

• Personal/family history of medullary thyroid carcinoma
• Multiple Endocrine Neoplasia type 2 (MEN2)
• History of pancreatitis
• Pregnancy (Category X) and breastfeeding
• Severe GI disease (gastroparesis)
• End-stage renal disease
• MEN2 syndrome
• Pancreatitis
• Severe renal impairment

Best Stacking Partners

Mechanism

Spermidine is an endogenous polyamine that induces autophagy primarily through inhibition of the acetyltransferase EP300 (p300), leading to hypoacetylation of multiple autophagy-related proteins and subsequent activation of the core autophagy machinery (Atg5, Atg7, Beclin-1). It promotes mitophagy (selective clearance of damaged mitochondria) and is essential for the hypusination of eukaryotic translation initiation factor 5A (eIF5A), a post-translational modification critical for TFEB-mediated lysosomal biogenesis. Spermidine also reduces age-related inflammation by suppressing NF-kB signaling and promotes cardiovascular health through improved endothelial nitric oxide bioavailability.

Standard Dosing

Research indicates 1-6 mg/day orally for longevity and autophagy support. Epidemiological data associates >80 micromol/day dietary spermidine intake with reduced cardiovascular mortality.

Timing

Morning with or without food. Some protocols suggest taking before a fasting period to potentiate autophagy (fasting naturally increases endogenous spermidine synthesis).

Cycle Duration

Ongoing. Endogenous spermidine levels decline with aging, suggesting lifelong supplementation may be beneficial.

Side Effects

• Generally very well-tolerated
• Mild GI discomfort at higher doses
• Headache (rare)

Contraindications

• Known hypersensitivity to polyamines
• Pregnancy and breastfeeding (insufficient safety data at supplemental doses)
• Active malignancy (polyamines promote cell proliferation in rapidly dividing cells — debated)
• Wheat allergy (if from wheat germ source)

Best Stacking Partners